True Wealth Design’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$100K Sell
189
-27
-13% -$12.5K 0.02% 262
2026
Q1
$104K Sell
216
-48
-18% -$24.6K 0.03% 204
2025
Q4
$148K Buy
264
+43
+19% +$24.4K 0.04% 119
2025
Q3
$114K Buy
221
+208
+1,600% +$90.8K 0.03% 138
2025
Q2
$4.08K Sell
13
-125
-91% -$37.5K ﹤0.01% 886
2025
Q1
$42K Sell
138
-120
-47% -$40.4K 0.02% 219
2024
Q4
$85.7K Buy
258
+89
+53% +$30.2K 0.03% 83
2024
Q3
$56.4K Buy
169
+168
+16,800% +$63.8K 0.02% 123
2024
Q2
$412 Buy
+1
New +$396 ﹤0.01% 683

Other funds holding MEDP

True Wealth Design's MEDP Position: Q2 2026 in Review

True Wealth Design reduced its Medpace (MEDP) stake by 13% in Q2 2026, selling an estimated $12.5K and leaving 189 shares worth $100K. The position accounts for 0.02% of the portfolio, ranked #262.

True Wealth Design first reported a position in MEDP in Q2 2024 and has held it in 9 quarters since. The position peaked at $148K in Q4 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • True Wealth Design held 189 shares of Medpace worth $100K as of Q2 2026.
  • True Wealth Design sold 27 Medpace shares in Q2 2026, an estimated $12.5K.
  • Medpace made up 0.02% of True Wealth Design's portfolio in Q2 2026, its #262 holding.
  • True Wealth Design first reported a position in Medpace in Q2 2024 and has held it in 9 quarters since.
  • True Wealth Design's Medpace position peaked at $148K in Q4 2025.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.